Clinical Trials Logo

Acute Brain Injury clinical trials

View clinical trials related to Acute Brain Injury.

Filter by:

NCT ID: NCT06426615 Recruiting - Clinical trials for Traumatic Brain Injury

Connectivity and Neural Signatures of Consciousness in Unresponsive States

CONSCIUS
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The CONSCIUS study is a prospective, interventional study including patients with acute brain injury and impaired consciousness implanted with intracranial electrodes. The aim of the study is to investigate seizures and thalamocortical neural dynamics underlying behavioral unresponsiveness.

NCT ID: NCT06393049 Not yet recruiting - Acute Brain Injury Clinical Trials

Microdialysis and Jugular Bulb Glucose Profiles During Hyperglycaemic Clamping in Patients With Severe Acute Brain Injury

CLAMP
Start date: May 8, 2024
Phase: N/A
Study type: Interventional

Acute brain injury is a serious condition that often results in admission to an intensive care unit. Some of the most seriously ill patients are fitted with multimodal neuromonitoring, a newer monitoring modality that can, among other things, measure oxygen tension and sugar levels in brain tissue. It is common clinical practice, but the interaction between the body's sugar levels and the brain's sugar levels is not sufficiently elucidated. The study will investigate the relationship between the body's sugar levels, measured in arterial and venous blood, and the brain's sugar level, measured by microdialysis, in patients with severe acute brain injury. Furthermore, we hope to be able to use our measurements to set up a mathematical model for the brain's sugar uptake.

NCT ID: NCT06302244 Active, not recruiting - Acute Brain Injury Clinical Trials

Multimodal Neuromonitoring in Acute Brain Injury

Start date: March 27, 2017
Phase:
Study type: Observational

Acute brain injury due to aneurysmal subarachnoid haemorrhage (SAH) or traumatic brain injury (TBI) is a condition with a high mortality, and surviving patients often have permanent disabilities. Multimodal neuromonitoring of intracranial pressure, brain tissue oxygen tension (PbtO2), and brain energy metabolism (measured with microdialysis (MD)) may help individualise the treatment of this patient group to protect the brain and potentially improve outcomes. However, there is still a significant lack of knowledge regarding the advantages and disadvantages of this type of monitoring. The present study consists of four substudies with the overall aim of examining which factors are most influential for regulating commonly measured intracerebral parameters such as oxygenation, glucose, and lactate. Additionally, the influence of these of parameters on functional outcome and mortality will be explored. The individual studies are detailed below:

NCT ID: NCT06267131 Recruiting - Acute Brain Injury Clinical Trials

Transcutaneous Pulse Oximetry Brain Monitoring Study (US)

T-POT US
Start date: October 27, 2023
Phase: N/A
Study type: Interventional

This is a study of adult patients with a severe and sudden brain injury who have a drain placed in their brain to measure pressure. The purpose of the study is to monitor the pressure in the brain using a monitor placed on the forehead, and compare this to a drain placed in the brain.

NCT ID: NCT06090812 Completed - Acute Brain Injury Clinical Trials

Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis

Start date: January 1, 2021
Phase:
Study type: Observational

In this study, we investigated the clinical variability in paroxysmal sympathetic hyperactivity in patients with acute brain injury and examined the prognostic value of the Paroxysmal Sympathetic Hyperactivity Assessment Measure (PSH-AM) in relation to Doppler ultrasound assessment of volume status, right heart function, and pulmonary edema. Thirty patients with ABI were prospectively enrolled. A correlation analysis between the PSH-AM score and related clinical indicators was performed using Pearson's or Spearman's correlation coefficient. Receiver operating characteristic curves were used to assess the prediction of the 6-month Glasgow Outcome Scale Extended score for neurorehabilitation prognosis.

NCT ID: NCT06083441 Recruiting - Clinical trials for Traumatic Brain Injury

SeeMe: An Automated Tool to Detect Early Recovery After Brain Injury

Start date: June 16, 2019
Phase:
Study type: Observational

Early prediction of outcomes after acute brain injury (ABI) remains a major unsolved problem. Presently, physicians make predictions using clinical examination, traditional scoring systems, and statistical models. In this study, we will use a novel technique, "SeeMe," to objectively assess the level of consciousness in patients suffering from comas following ABI. SeeMe is a program that quantifies total facial motion over time and compares the response after a spoken command (i.e. "open your eyes") to a pre-stimulus baseline.

NCT ID: NCT06074406 Recruiting - Clinical trials for Extracorporeal Membrane Oxygenation Complication

Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The primary object of the study is to further characterize safety and feasibility of low-field bedside MRI in pediatric and neonatal ECMO patients. To perform imaging assessments of an early-stage magnetic resonance imaging (MRI) system on patients using low field magnetic strength. Collect qualitative data from the image assessments to optimize device performance using a low field magnetic resonance imaging device in a simulated use environment; Collect qualitative data from the image assessments using a high field magnetic resonance imaging, computed tomography and ultrasound devices. Generate anonymized image data for post-acquisition evaluation, performance measuring and planning for subsequent study size

NCT ID: NCT05506241 Recruiting - Stroke Clinical Trials

Effectiveness of the Dynavision Device to Improve Spatial Awareness After Brain Injury

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to determine the effectiveness of using the Dynavision D2 to improve left neglect in adults with brain injury, and improve performance of ADLs/IADLs. This study will use a randomized control trial at Providence Care Hospital in Kingston Ontario, with clients admitted to the Stroke and ABI services who have been identified through the Catherine Bergego Scale (CBS) as having moderate to severe left neglect. Individuals will be randomly assigned to the control arm, where they will get the usual 60 minutes of OT treatment daily or the intervention arm, which is 30 minutes of their usual OT treatment and a 30 minute session of the Dynavision for 10 sessions for short stay inpatients (~ 3 weeks) and 20 sessions for clients with longer 5-6 week stay. The CBS will be used to measure change in neglect severity at three time points: baseline, following 10 sessions and following 20 sessions, for those that stay for longer.

NCT ID: NCT05505396 Recruiting - Hyperglycemia Clinical Trials

Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury

BRAIN-GLULAC
Start date: October 24, 2022
Phase:
Study type: Observational

This is an observational study of patients with severe acute brain injury, which aims to characterize the development of hyperglycaemia and hyperlactataemia and the influence of these markers on clinical outcome. Additionally, in a subgroup of patients undergoing advanced multimodal neuromonitoring on either clinical or research indication, the relationship between hyperglycaemia and brain glucose levels as well as systemic and microdialysis lactate will be examined.

NCT ID: NCT05469139 Completed - Clinical trials for Extracorporeal Membrane Oxygenation Complication

Assessing Brain Injury Using Portable Magnetic Resonance Imaging (MRI)

SAFE MRI
Start date: December 10, 2021
Phase:
Study type: Observational

This study aims to assess the feasibility of assessing acute brain injury using a portable low field MRI in patients on ECMO.